Source: JAMA Neurology. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, ESCLEROSE MÚLTIPLA, TRANSPLANTE AUTÓLOGO, SOBREVIVÊNCIA LIVRE DE DOENÇA
ABNT
MURARO, Paolo A. et al. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurology, v. 74, n. 4, p. 459-469, 2017Tradução . . Disponível em: https://doi.org/10.1001/jamaneurol.2016.5867. Acesso em: 19 out. 2024.APA
Muraro, P. A., Pasquini, M., Atkins, H. L., Bowen, J. D., Farge, D., Fassas, A., et al. (2017). Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurology, 74( 4), 459-469. doi:10.1001/jamaneurol.2016.5867NLM
Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Simões BP. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. JAMA Neurology. 2017 ; 74( 4): 459-469.[citado 2024 out. 19 ] Available from: https://doi.org/10.1001/jamaneurol.2016.5867Vancouver
Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Simões BP. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. JAMA Neurology. 2017 ; 74( 4): 459-469.[citado 2024 out. 19 ] Available from: https://doi.org/10.1001/jamaneurol.2016.5867